Can losing weight cure a brain pressure disorder? new study investigates

NCT ID NCT06913712

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 25 adults with idiopathic intracranial hypertension (IIH), a condition where high pressure inside the skull causes headaches and vision problems. Researchers will measure body mass index (BMI) every three months and see how it relates to the success of treatments like weight loss, diuretics, or shunts. The goal is to find out how much weight loss is needed to achieve remission and why some people don't improve even with treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify specific BMI targets that help doctors guide weight loss as a treatment for idiopathic intracranial hypertension, potentially leading to remission without drugs or surgery.
What could go wrong
This is a small observational study (25 people) that only looks at patterns, not testing a new treatment. Results may not apply to everyone, and weight loss is difficult to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC INTRACRANIAL HYPERTENSION (IIH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Consorcio Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Valencia, 46015, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.